Posts Tagged "AbbVie hepatitis C drug"

U.S. FDA approves AbbVie hepatitis C drug, costs $83,319 for 12 weeks

Posted on Feb 3, 2015 in News

U.S. health regulators on Friday approved AbbVie’s all-oral treatment for hepatitis C, and the company said the drug would cost $83,319 for a typical 12-week plan, a bit below its huge selling competitor Sovaldi from Gilead Sciences. Gilead’s Sovaldi treatment stole headlines last year with its $84,000 price tag and set off a national debate about whether drug prices have climbed too high. AbbVie’s newly approved regimen is also less costly than Gilead’s newest one-pill regimen that combines Sovaldi with another drug and costs $94,500 for 12 weeks. With Gilead’s...

Read More